32.25
3.86%
+1.20
アフターアワーズ:
32.10
-0.15
-0.47%
PTC Therapeutics Inc (PTCT) 最新ニュース
Compared to Estimates, PTC Therapeutics (PTCT) Q1 Earnings: A Look at Key Metrics
Zacks Investment Research
PTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Zacks Investment Research
Biotech Stock Roundup: GERN, CRNX Gain on Updates, BMY's CAR T Cell Therapy News & More
Zacks Investment Research
PTC Therapeutics (PTCT) Up on Positive Regulatory Updates
Zacks Investment Research
Cooper Companies Reports Upbeat Results, Joins Dell, NetApp, Tidewater And Other Big Stocks Moving Higher On Friday
Benzinga
Here's What Key Metrics Tell Us About PTC Therapeutics (PTCT) Q4 Earnings
Zacks Investment Research
PTC Therapeutics (PTCT) Reports Q4 Loss, Lags Revenue Estimates
Zacks Investment Research
Wall Street's Insights Into Key Metrics Ahead of PTC Therapeutics (PTCT) Q4 Earnings
Zacks Investment Research
Will Karyopharm Therapeutics (KPTI) Report Negative Q4 Earnings? What You Should Know
Zacks Investment Research
PTC Therapeutics (PTCT) to Report Q4 Results: Wall Street Expects Earnings Growth
Zacks Investment Research
1 of Sarepta Therapeutics' Competitors Just Got Hammered. Will It Help the Stock?
The Motley Fool
Strength Seen in Enanta Pharmaceuticals (ENTA): Can Its 13.8% Jump Turn into More Strength?
Zacks Investment Research
Biogen's (BIIB) Rare Disease Drug Skyclarys Gets CHMP Nod in EU
Zacks Investment Research
Solid Biosciences' (SLDB) DMD Drug Gets Fast Track Tag, Stock Up
Zacks Investment Research
Entrada (TRDA) Down on FDA Maintaining Clinical Hold on DMD Drug
Zacks Investment Research
Analyst Expectations for PTC Therapeutics's Future
Benzinga
Solid Biosciences (SLDB) Stock Up as FDA Clears DMD Drug IND
Zacks Investment Research
大文字化:
|
ボリューム (24 時間):